In February 2026, XellSmart Pharmaceutical Co., Ltd. (XellSmart) announced that it had secured its fourth US FDA and China NMPA clearance for Phase I/II registrational clinical trial entry with its ...
Acadia Pharmaceuticals Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) informed the company it has formally adopted a ...
A groundbreaking international clinical trial has been testing an implanted adaptive deep brain stimulation (aDBS) device as a treatment therapy for Parkinson’s.
Michael Leo’s dodging and adaptability have powered Syracuse men’s lacrosse’s offense. Leo hopes it’ll lead him and the 2022 ...
After an out-and-out disaster of a day on face-offs (6-of-18 overall), Johnny Mullen came through with a clean, easy win to earn possession. After a few simple passes up top, the ball found Luke Rhoa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results